Results 201 to 210 of about 66,079 (291)

Observational Study of the Impact of Infusion Set Replacement in Insulin Pump Users on Glycemic Management. [PDF]

J Diabetes Sci Technol
Yoshimura K, Urai S, Hozumi K, Nakatsuji M, Saito S, Nishikage S, Yamamoto A, Takayoshi T, Ogawa W, Hirota Y.   +9 more
europepmc   +1 more source

Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Evaluate performance of the Predicting Risk of Cardiovascular Disease Events (PREVENT) calculator in rheumatoid arthritis (RA). Methods Patients with RA were matched up to 10 controls on age, sex, and enrollment year using National Veterans Health Administration, Medicare, and National Death Index data (2006–2020).
Tate M. Johnson, Halie Frideres, Punyasha Roul, Joshua F. Baker, Brian C. Sauer, Grant W. Cannon, Isaac D. Smith, Gary A. Kunkel, Beth I. Wallace, Thomas R. Porter, Kaveh R. Bookani, Amarnath R. Annapureddy, Ted R. Mikuls, Bryant R. England   +13 more
wiley   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Tubeless Insulin Pump Combined with a Cloud-Based Data Management Platform: Real-World Evidence from 14,765 French People with Diabetes. [PDF]

Diabetes Ther
Jeandidier N, Bagel A, Bonin A, Guigand G, Guerci B.   +4 more
europepmc   +1 more source

Use of Insulin Pumps in the Perioperative Patient

, 2016
Judith Raboy
openalex   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Enhancing Diabetes Management in Remote Regions: Insulin Pump Adaption and Safety in the Faroe Islands. [PDF]

AACE Endocrinol Diabetes
Andreassen J, Nikontovic A, Iversen EM, Borðoy RÁF, Rasmussen P, Petersen MS, Johannesen HL.   +6 more
europepmc   +1 more source

<b>Designing a Structured Insulin Pump Program Pathway and Reducing Wait Times in the Diabetes Clinic at BC Children’s Hospital</b>

Fatema S. Abdulhussein, Sanjukta Basak, Deep McGregor, Hannah Breadon, Erica Vance, Jillian Creagh, Tavia Moffitt, Sharleen Herrmann, Shayni Morgan, Shazhan Amed   +9 more
openalex   +1 more source

Medical versus science students: Knowledge, perceptions and learning of core pharmacology concepts

British Journal of Clinical Pharmacology, EarlyView.
Aims Pharmacology is a core discipline underpinning both medical and biomedical science education, essential for understanding drug action, safety and therapeutic efficacy. This study compared pharmacology knowledge, perceptions and learning experiences between second‐year medical and science students to evaluate how effectively each curriculum ...
Zina Alfahl, Rachel Lynch, Cara O'Dwyer, John P. Kelly   +3 more
wiley   +1 more source

Effect of short-term intensive insulin pump therapy on serum endotrophin levels in patients with newly diagnosed type 2 diabetes. [PDF]

Front Endocrinol (Lausanne)
Li Y, Gui X, Weng Y, Xun L, Yu W, Xiang C, Qi X, Wang X, Bai F.   +8 more
europepmc   +1 more source